- New
Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in recent years. It is a glucagon-like peptide-1 (GLP-1) agonist, which mimics the GLP-1 hormone. GLP-1 is a hormone in the gut that is released in response to eating. In higher amounts, it interacts with the brain in a manner that suppresses appetite and causes a lasting feeling of fullness.
For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, and must not be misused in any way that contravenes MHRA regulations or applicable laws.
Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in recent years. It is a glucagon-like peptide-1 (GLP-1) agonist, which mimics the GLP-1 hormone. GLP-1 is a hormone in the gut that is released in response to eating. In higher amounts, it interacts with the brain in a manner that suppresses appetite and causes a lasting feeling of fullness.
After 68 weeks, half of clinical trial participants lost 17% of their initial body weight, and another third lost 20% with improved diet and exercise. Many individuals regained weight after stopping the medication, which highlights the importance of long-term strategy.
Other Benefits
Side Effects
Of all GLP-1 medications, Semaglutide has one of the highest rates of side effects. These may include:
Less Common but More Serious Side Effects
Contraindications
Do NOT take Semaglutide if:
Consult your physician before use if you have:
Stacking Suggestions
Pancragen may help to reduce desensitization in long-term users.
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent
Write your review
Review sent
Your review cannot be sent
Reference: GLUTA1500
Reference: BAC10
Reference: HEX3
Reference: 51MQ50
Reference: EPI50
Reference: IGF1
Reference: MITOBLEND
Originally developed as a medication to treat Type-2 Diabetes, Semaglutide has been adopted as an effective tool to combat obesity in recent years. It is a glucagon-like peptide-1 (GLP-1) agonist, which mimics the GLP-1 hormone. GLP-1 is a hormone in the gut that is released in response to eating. In higher amounts, it interacts with the brain in a manner that suppresses appetite and causes a lasting feeling of fullness.
For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, and must not be misused in any way that contravenes MHRA regulations or applicable laws.
check_circle
check_circle